SUVRETTA CAPITAL MANAGEMENT LLC 13D and 13G filings for Sutro Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-13 8:47 pm Purchase | 2025-06-30 | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT LLC | 648,832 7.700% | 71,014 (+12.29%) | Filing |
| 2024-02-13 12:16 pm Purchase | 2023-12-31 | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT LLC | 577,819 9.500% | 21,309 (+3.83%) | Filing |
| 2023-02-13 10:56 am Purchase | 2022-12-31 | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT LLC | 556,510 9.700% | 309,130 (+124.96%) | Filing |
| 2022-02-11 4:49 pm Purchase | 2021-12-31 | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT LLC | 247,380 5.400% | 6,540 (+2.72%) | Filing |
| 2021-12-10 4:31 pm Purchase | 2021-11-30 | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT LLC | 240,840 5.200% | 240,840 (New Position) | Filing |